Drawing for SPYBIOTECH

USPTO serial 79975699

SPYBIOTECH

Reviewed by CopyMark Law Group

Reg. 7153093Status 700Registered
Filing date
Status date
Registration date
Sep 5, 2023
Examiner
CLARK, ANDREW T
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SPYBIOTECH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ben Natter

Ben Natter Haug Partners, LLP745 Fifth AvenueNew York, NY 10151UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical, biopharmaceutical and medicinal preparations and substances for the treatment of ophthalmological conditions, hearing loss, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, fibrosis, hepatic diseases, renal diseases, diseases of the pancreas, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; vaccines; vaccine preparations; all of the foregoing for exclusive use in the vaccine and viral based therapeutics fieldACTIVE—
042Medical and pharmaceutical research services; biological research; development of pharmaceutical preparations and medicines; research and development relating to biologics and vaccines; providing medical and scientific research information in the field of pharmaceuticals and vaccines; scientific research in the nature of conducting clinical trials for others in the vaccine and viral based therapeutics field; scientific and medical research consulting services in the nature of clinical trial design for vaccines for others; providing a bioinformatics platform for use in manufacturing therapeutics in the nature of platform as a service (PAAS) featuring computer software for medical data analysis; scientific services relating to the discovery, preclinical and clinical development of vaccines and therapeutic products in the nature of development of pharmaceutical preparations and medicines; research and development of new products for others; development of pharmaceutical products for others; information, advisory and consultancy services relating to the aforesaidACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 2, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 7, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 7, 2023FIMPFINAL DISPOSITION PROCESSED—
Dec 5, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 5, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 5, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 20, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 20, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 19, 2023GPNXNOTIFICATION PROCESSED BY IB—
May 31, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 31, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 31, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 17, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 18, 2023MNDANOTICE OF DIVIDED TRADEMARK APPLICATION MAILED—
Apr 12, 2023DPCCDIVISIONAL PROCESSING COMPLETE—
Apr 12, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 4, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 15, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 15, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 15, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 13, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 13, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Feb 27, 2023DRRRDIVISIONAL REQUEST RECEIVED—
Feb 27, 2023ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Jan 13, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 13, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 13, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 21, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 21, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 21, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 19, 2022RFNTREFUSAL PROCESSED BY IB—
Jun 28, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 28, 2022RFRRREFUSAL PROCESSED BY MPU—
Jun 15, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 14, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 13, 2022RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
Jun 7, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 6, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 20, 2022DOCKASSIGNED TO EXAMINER—
Oct 19, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 15, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 14, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance